参考文献/References:
［1］杨学刚，周石，吴戈，等介入动脉灌注化疗联合放疗治疗局部晚期宫颈癌的临床疗效研究 ［J］中华放射学杂志，2013，47（9）：840-842
［2］Eskander RN, Tewari KS. Chemotherapy in the treatment of etastatic,persistent,and recurrent cervical cancer ［J］. Curr Opin Obstet Gynecol, 2014, 26(4): 314-321.
［3］Garcia LM, Hemmelgarn M, Pineda E, et al. Cervical cancer treatment and survivorship needs:The patient's perspective ［J］. Gynecol Oncol, 2014, 133(Suppl 1): 51-52.
［4］Chen SJ, Kuo CC, Pan HY, et al. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo ［J］. Biochem Pharmacol, 2015, 95(1): 28-37.
［5］陈惠祯，蔡红兵现代妇科肿瘤学 ［M］湖北：科学技术出版社，2006：206-207
［6］汤钊猷现代肿瘤学 ［M］第2版上海：上海医科大学出版社，2000：3-10
［7］Phua VC, Wong WQ, TAN Pei-lin, et al. Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in Asian cancer patients in clinical practice ［J］. Asian Pac J Cancer Prev, 2015, 16(4): 1449-1453.
［8］Hosaka M, Watari H, Kato T, et al. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy ［J］. J Surg Oncol, 2012, 105(6): 612-616.
［9］WEI Li-chun, WANG Ning, SHI Mei, et al. Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma ［J］. Onco Targets Ther, 2013, 6(6): 67-74.
［10］Fornage BD, Hwang RF. Current status of imaging-guided percutaneous ablation of breast cancer ［J］. AJR Am J Roentgenol, 2014, 203(2): 442-448.
［11］Limani K, Aoun F, Holz S, et al. Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer:10-year outcomes ［J］. Prostate Cancer, 2014, 20(14): 186782.
［12］Moyer VA, U. S.preventive services task force.Screening for cervical cancer:U.S.preventive services task force recommendation statement ［J］. Ann Intern Med, 2014, 160(1): 55-60.
［13］Abe A, Furumoto H, Nishimura M, et al. Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy ［J］. Oncol Lett, 2012, 3(3): 571-576.
［14］YIN Mingzhu, ZHANG Haiyu, LI Huiyan, et al. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer ［J］. J Surg Oncol, 2012, 105(2): 206-211.
［15］Motoyama S, Humana S, KU Y, et al. Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients withstages Ⅲa-Ⅳa cervical cancer ［J］. Gynecol Oncol, 2012, 95(3): 576-582.
［16］YU Ting-he, FU Xiao. Extracorporeal ultrasound-guided high intensity focused ultrasound: implications from the present clinical trials ［J］. Scientific World Journal, 20(14): 537260.
相似文献/References:
[1]李菁,沈立翡,朱岚,等.新辅助化疗联合间隔减瘤术在晚期卵巢癌中的临床应用研究[J].中国计划生育和妇产科,2015,(11):0.
LI Jing,SHEN Li-fei,ZHU Lan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(8):0.
[2]綦小蓉 综述,何跃东* 审校.晚期卵巢癌选择初始肿瘤细胞减灭术还是间歇性肿瘤细胞减灭术探析[J].中国计划生育和妇产科,2018,(4):26.
[3]杨辰敏,冯炜炜,蔡蕾*.放化疗和手术的不同组合在治疗ⅡB~ⅣA期
宫颈癌的研究进展[J].中国计划生育和妇产科,2019,(6):30.
[4]朵雪莲*,马梅艳,白盖措.盆腔淋巴结切除数目对不同治疗方案的宫颈癌患者无进展生存时间的影响[J].中国计划生育和妇产科,2019,(9):47.
DUO Xue-lian*,MA Mei-yan,BAI Gai-cuo.Effect of number of pelvic lymph node resection on progression-free survival of cervical cancer patients with different treatment regimens[J].Chinese Journal of Family Planning & Gynecotokology,2019,(8):47.